Low Expression of Keratin17 is Related to Poor Prognosis in Bladder Cancer

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A. Epidemiology of bladder cancer. Med Sci (Basel). 2020;8. doi:10.3390/medsci8010015
   PubMedGoogle Scholar
• Li B, Xie F, Zheng FX, Jiang GS, Zeng FQ, Xiao XY. Overexpression of CircRNA BCRC4 regulates cell apoptosis and MicroRNA-101/EZH2 signaling in bladder cancer. J Huazhong Univ Sci Technol Med Sci. 2017;37(6):886–890. doi:10.1007/s11596-017-1822-9
   PubMedGoogle Scholar
• Peng D, Gong YQ, Hao H, et al. Preoperative prognostic nutritional index is a significant predictor of survival with bladder cancer after radical cystectomy: a retrospective study. BMC Cancer. 2017;17(1):391. doi:10.1186/s12885-017-3372-8
   PubMed Web of Science ®Google Scholar
• Wang QH, Ji JL, Li H, et al. Preoperative lymphocyte-to-monocyte ratio predicts prognosis in patients with stage T1 non-muscle invasive bladder cancer. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019;41(5):622–629. doi:10.3881/j.issn.1000-503X.11227
   PubMedGoogle Scholar
• Boubaker NS, Gurtner A, Trabelsi N, et al. Evaluating prognostic utility of preoperative neutrophil to lymphocyte ratio and hsa-let-7g/c up-regulation in patients with urinary bladder cancer. Cancer Biomark. 2020;27(1):63–73. doi:10.3233/CBM-190483
   PubMed Web of Science ®Google Scholar
• Zhang GM, Zhu Y, Luo L, et al. Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy. Tumour Biol. 2015;36(11):8537–8543. doi:10.1007/s13277-015-3613-x
   PubMedGoogle Scholar
• Shi J, Zhang P, Liu L, Min X, Xiao Y. Weighted gene coexpression network analysis identifies a new biomarker of CENPF for prediction disease prognosis and progression in nonmuscle invasive bladder cancer. Mol Genet Genomic Med. 2019;7(11):e982. doi:10.1002/mgg3.982
   PubMed Web of Science ®Google Scholar
• Ding W, Gou Y, Sun C, et al. Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC. Urol Oncol. 2014;32(42):e13–9. doi:10.1016/j.urolonc.2013.05.004
   Google Scholar
• Kimura S, Soria F, D’Andrea D, et al. Prognostic value of serum cholinesterase in non-muscle-invasive bladder cancer. Clin Genitourin Cancer. 2018;16(6):e1123–e32. doi:10.1016/j.clgc.2018.07.002
   PubMed Web of Science ®Google Scholar
• Afferi L, Moschini M, Cumberbatch MG, et al. European association of urology - European society of resident U. biomarkers predicting oncological outcomes of high-risk non-muscle-invasive bladder cancer. Minerva Urol Nefrol. 2020;72(3):265–278. doi:10.23736/S0393-2249.20.03786-8
   PubMed Web of Science ®Google Scholar
• Yoon S, Leube RE, Malliri A, Caswell P, Ballestrem C, Hurlstone A. Keratin intermediate filaments: intermediaries of epithelial cell migration. Essays Biochem. 2019;63(5):521–533. doi:10.1042/EBC20190017
   PubMed Web of Science ®Google Scholar
• Jacob JT, Coulombe PA, Kwan R, Omary MB, Types I, Keratin intermediate II. Filaments. Cold Spring Harb Perspect Biol. 2018;10(4):10. doi:10.1101/cshperspect.a018275
   Web of Science ®Google Scholar
• Salas PJ, Forteza R, Mashukova A. Multiple roles for keratin intermediate filaments in the regulation of epithelial barrier function and apico-basal polarity. Tissue Barriers. 2016;4(3):e1178368. doi:10.1080/21688370.2016.1178368
   PubMed Web of Science ®Google Scholar
• Oriolo AS, Wald FA, Ramsauer VP, Salas PJ. Intermediate filaments: a role in epithelial polarity. Exp Cell Res. 2007;313(10):2255–2264. doi:10.1016/j.yexcr.2007.02.030
   PubMed Web of Science ®Google Scholar
• Soudy R, Etayash H, Bahadorani K, Lavasanifar A, Kaur K. Breast cancer targeting peptide binds keratin 1: a new molecular marker for targeted drug delivery to breast cancer. Mol Pharm. 2017;14(3):593–604. doi:10.1021/acs.molpharmaceut.6b00652
   PubMed Web of Science ®Google Scholar
• Yan X, Yang C, Hu W, et al. Knockdown of KRT17 decreases osteosarcoma cell proliferation and the Warburg effect via the AKT/mTOR/HIF1alpha pathway. Oncol Rep. 2020;44(1):103–114. doi:10.3892/or.2020.7611
   PubMed Web of Science ®Google Scholar
• Depianto D, Kerns ML, Dlugosz AA, Coulombe PA. Keratin 17 promotes epithelial proliferation and tumor growth by polarizing the immune response in skin. Nat Genet. 2010;42(10):910–914. doi:10.1038/ng.665
   PubMed Web of Science ®Google Scholar
• Kim CY, Jung WY, Lee HJ, Kim HK, Kim A, Shin BK. Proteomic analysis reveals overexpression of moesin and cytokeratin 17 proteins in colorectal carcinoma. Oncol Rep. 2012;27(3):608–620. doi:10.3892/or.2011.1545
   PubMed Web of Science ®Google Scholar
• Chivu-Economescu M, Dragu DL, Necula LG, et al. Knockdown of KRT17 by siRNA induces antitumoral effects on gastric cancer cells. Gastric Cancer. 2017;20(6):948–959. doi:10.1007/s10120-017-0712-y
   PubMed Web of Science ®Google Scholar
• Dong M, Dong Z, Zhu X, Zhang Y, Song L. Long non-coding RNA MIR205HG regulates KRT17 and tumor processes in cervical cancer via interaction with SRSF1. Exp Mol Pathol. 2019;111:104322. doi:10.1016/j.yexmp.2019.104322
   PubMed Web of Science ®Google Scholar
• Sarlos DP, Yusenko MV, Peterfi L, Szanto A, Kovacs G. Dual role of KRT17: development of papillary renal cell tumor and progression of conventional renal cell carcinoma. J Cancer. 2019;10(21):5124–5129. doi:10.7150/jca.32579
   PubMed Web of Science ®Google Scholar
• Li D, Ni XF, Tang H, et al. KRT17 functions as a tumor promoter and regulates proliferation, migration and invasion in pancreatic cancer via mTOR/S6k1 pathway. Cancer Manag Res. 2020;12:2087–2095. doi:10.2147/CMAR.S243129
   PubMed Web of Science ®Google Scholar
• Wang Z, Yang MQ, Lei L, et al. Overexpression of KRT17 promotes proliferation and invasion of non-small cell lung cancer and indicates poor prognosis. Cancer Manag Res. 2019;11:7485–7497. doi:10.2147/CMAR.S218926
   PubMed Web of Science ®Google Scholar
• Wang Y, Zheng T. Screening of hub genes and pathways in colorectal cancer with microarray technology. Pathol Oncol Res. 2014;20(3):611–618. doi:10.1007/s12253-013-9739-5
   PubMed Web of Science ®Google Scholar
• Laurberg JR, Jensen JB, Schepeler T, Borre M, Orntoft TF, Dyrskjot L. High expression of GEM and EDNRA is associated with metastasis and poor outcome in patients with advanced bladder cancer. BMC Cancer. 2014;14(1):638. doi:10.1186/1471-2407-14-638
   PubMedGoogle Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• Kabir NN, Ronnstrand L, Kazi JU. Keratin 19 expression correlates with poor prognosis in breast cancer. Mol Biol Rep. 2014;41(12):7729–7735. doi:10.1007/s11033-014-3684-6
   PubMed Web of Science ®Google Scholar
• Chen L, Wang Y, Zhao L, et al. Hsp74, a potential bladder cancer marker, has direct interaction with keratin 1. J Immunol Res. 2014;2014:492849. doi:10.1155/2014/492849
   PubMed Web of Science ®Google Scholar
• Hu HB, Yang XP, Zhou PX, Yang XA, Yin B. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma. Genes Genomics. 2020;42(2):179–188. doi:10.1007/s13258-019-00889-5
   PubMed Web of Science ®Google Scholar
• Mertz KD, Demichelis F, Sboner A, et al. Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer. Int J Cancer. 2008;123(3):569–576. doi:10.1002/ijc.23565
   PubMed Web of Science ®Google Scholar
• Buhler H, Schaller G. Transfection of keratin 18 gene in human breast cancer cells causes induction of adhesion proteins and dramatic regression of malignancy in vitro and in vivo. Mol Cancer Res. 2005;3(7):365–371. doi:10.1158/1541-7786.MCR-04-0117
   PubMed Web of Science ®Google Scholar
• Quan Y, Xu M, Cui P, Ye M, Zhuang B, Min Z. Grainyhead-like 2 promotes tumor growth and is associated with poor prognosis in colorectal cancer. J Cancer. 2015;6(4):342–350. doi:10.7150/jca.10969
   PubMed Web of Science ®Google Scholar
• Sejima T, Morizane S, Yao A, et al. Prognostic impact of preoperative hematological disorders and a risk stratification model in bladder cancer patients treated with radical cystectomy. Int J Urol. 2014;21(1):52–57. doi:10.1111/iju.12161
   PubMed Web of Science ®Google Scholar
• Sommers CL, Byers SW, Thompson EW, Torri JA, Gelmann EP. Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat. 1994;31(2–3):325–335. doi:10.1007/BF00666165
   PubMed Web of Science ®Google Scholar
• Conacci-Sorrell M, Zhurinsky J, Ben-Ze’ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest. 2002;109(8):987–991. doi:10.1172/JCI15429
   PubMed Web of Science ®Google Scholar
• Smith EA, Fuchs E. Defining the interactions between intermediate filaments and desmosomes. J Cell Biol. 1998;141(5):1229–1241. doi:10.1083/jcb.141.5.1229
   PubMed Web of Science ®Google Scholar
• Escobar-Hoyos LF, Shah R, Roa-Pena L, et al. Keratin-17 promotes p27 KIP1 nuclear export and degradation and offers potential prognostic utility. Cancer Res. 2015;75(17):3650–3662. doi:10.1158/0008-5472.CAN-15-0293
   PubMed Web of Science ®Google Scholar